» Authors » Aokun Chen

Aokun Chen

Explore the profile of Aokun Chen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 216
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Xie Q, Chen Q, Chen A, Peng C, Hu Y, Lin F, et al.
NPJ Digit Med . 2025 Mar; 8(1):141. PMID: 40044845
Recent advancements in large language models (LLMs) show significant potential in medical applications but are hindered by limited specialized medical knowledge. We present Me-LLaMA, a family of open-source medical LLMs...
2.
Xie Q, Chen Q, Chen A, Peng C, Hu Y, Lin F, et al.
Res Sq . 2025 Jan; PMID: 39764122
Recent advancements in large language models (LLMs) like ChatGPT and LLaMA have shown significant potential in medical applications, but their effectiveness is limited by a lack of specialized medical knowledge...
3.
Chen A, Paredes D, Yu Z, Lou X, Brunson R, Thomas J, et al.
Proc (IEEE Int Conf Healthc Inform) . 2024 Dec; 2024:305-311. PMID: 39726986
Delirium is an acute decline or fluctuation in attention, awareness, or other cognitive function that can lead to serious adverse outcomes. Despite the severe outcomes, delirium is frequently unrecognized and...
4.
Chen J, Kuang H, Chen A, Dungan J, Cousin L, Cong X, et al.
Pain Manag Nurs . 2024 Dec; 26(1):33-39. PMID: 39690039
Objectives: To examine the pain conditions that have been studied using transcutaneous auricular vagus nerve stimulation (taVNS), the various methods and dosage configurations used, as well as identify current gaps...
5.
Chen W, Li Y, Chen A, Allen J, Guo Y, Bilello L, et al.
J Manag Care Spec Pharm . 2024 Oct; 30(11):1298-1307. PMID: 39471265
Background: Two classes of newer glucose-lowering drugs (GLDs), sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists, improve cardiovascular and renal outcomes among patients with type 2 diabetes (T2D). However, racial...
6.
Yang S, Yang X, Lyu T, Huang J, Chen A, He X, et al.
J Healthc Inform Res . 2024 Aug; 8(3):463-477. PMID: 39131104
Supplementary Information: The online version contains supplementary material available at 10.1007/s41666-024-00166-5.
7.
Chen A, Li Q, Shenkman E, Wu Y, Guo Y, Bian J
Proc (IEEE Int Conf Healthc Inform) . 2024 Jul; 2023:756-759. PMID: 39070248
Clinical trials were vital tools to prove the effectiveness and safety of medications. To maximize generalizability, the study sample should represent the sample population and the target population. However, the...
8.
Xie Q, Chen Q, Chen A, Peng C, Hu Y, Lin F, et al.
Res Sq . 2024 Jun; PMID: 38826372
Recent advancements in large language models (LLMs) such as ChatGPT and LLaMA have hinted at their potential to revolutionize medical applications, yet their application in clinical settings often reveals limitations...
9.
Wang C, Chen A, He X, Balian P, George T, Wang F, et al.
medRxiv . 2024 Apr; PMID: 38633798
This study investigates the impact of clinical trial eligibility criteria on patient survival and serious adverse events (SAEs) in colorectal cancer (CRC) drug trials using real-world data. We utilized the...
10.
Peng C, Yang X, Chen A, Yu Z, Smith K, Costa A, et al.
J Am Med Inform Assoc . 2024 Apr; 31(9):1892-1903. PMID: 38630580
Objective: To solve major clinical natural language processing (NLP) tasks using a unified text-to-text learning architecture based on a generative large language model (LLM) via prompt tuning. Methods: We formulated...